Suppr超能文献

生物反馈辅助放松训练和分散注意力疗法在接受肉毒杆菌神经毒素 A 注射治疗的儿童疼痛中的应用:一项交叉随机对照试验。

Biofeedback assisted relaxation training and distraction therapy for pain in children undergoing botulinum neurotoxin A injections: A crossover randomized controlled trial.

机构信息

Children's Hospital Westmead Clinical School, Discipline of Child & Adolescent Health, the University of Sydney, Sydney, New South Wales, Australia.

Kids Rehab, the Children's Hospital at Westmead, Sydney, New South Wales, Australia.

出版信息

Dev Med Child Neurol. 2022 Dec;64(12):1507-1516. doi: 10.1111/dmcn.15303. Epub 2022 Jun 5.

Abstract

AIM

To compare biofeedback assisted relaxation training (BART) with distraction therapy for pain during botulinum neurotoxin A (BoNT-A) treatment.

METHOD

This was a crossover randomized controlled trial. Eligible participants were 7 years and older with neurological conditions. Participants were randomized to receive BART or distraction during their first BoNT-A treatment, followed by the alternative intervention in their subsequent BoNT-A treatment. BART was delivered via BrightHearts, an interactive heart-rate-responsive application. Outcomes were pain (Faces Pain Scale - Revised), fear (Children's Fear Scale), and anxiety (numerical rating scale, State-Trait Anxiety Inventory). Demographics, paired t-tests, and linear mixed models were used to compare outcomes.

RESULTS

Thirty-eight participants (mean [SD] age 13 years 5 months [3 years 4 months], 20 males, 34 with cerebral palsy) completed both interventions. There were non-significant differences in overall pain (mean difference - 0.05, 95% confidence interval [CI] -0.91 to 0.80, p = 0.902) and worst pain (mean difference 0.37, 95% CI -0.39 to 1.13, p = 0.334) when using BART and distraction therapy. There were non-significant differences in fear and anxiety between interventions. Younger age, heightened pre-procedural state anxiety, and Gross Motor Function Classification System levels III and IV were associated with poorer outcomes (p < 0.05). Participants who received BART before distraction therapy reported lower pain and anxiety scores during both BoNT-A treatments (p < 0.05).

INTERPRETATION

Children reported similar pain when using BART and distraction therapy. Those who used BART before distraction therapy reported lower pain and anxiety during both treatments.

WHAT THIS PAPER ADDS

Children reported similar pain (overall; worst) when using biofeedback assisted relaxation training (BART) and distraction therapy. Children who used BART before distraction therapy reported lower pain and anxiety over both botulinum neurotoxin A treatments. Younger age, pre-procedural state anxiety, and Gross Motor Function Classification System levels III and IV predicted a worse pain experience. Distraction therapy and BART were acceptable non-pharmacological interventions for procedural pain management.

摘要

目的

比较生物反馈放松训练(BART)与分散注意力疗法在肉毒毒素 A(BoNT-A)治疗中的疼痛缓解效果。

方法

这是一项交叉随机对照试验。符合条件的参与者为 7 岁及以上患有神经疾病的儿童。参与者随机接受 BART 或分散注意力治疗,作为其首次 BoNT-A 治疗的干预手段,随后在后续 BoNT-A 治疗中接受另一种干预手段。BART 通过 BrightHearts 进行,这是一种交互式心率反应应用程序。主要结局为疼痛(面部疼痛评分修订版)、恐惧(儿童恐惧量表)和焦虑(数字评分量表、状态-特质焦虑量表)。采用描述性统计、配对 t 检验和线性混合模型对结果进行比较。

结果

38 名参与者(平均[标准差]年龄 13 岁 5 个月[3 岁 4 个月],20 名男性,34 名脑瘫患儿)完成了两项干预措施。BART 和分散注意力治疗的总体疼痛(平均差值-0.05,95%置信区间[CI]-0.91 至 0.80,p=0.902)和最痛(平均差值 0.37,95%CI-0.39 至 1.13,p=0.334)差异无统计学意义。两种干预措施在恐惧和焦虑方面差异无统计学意义。年龄较小、术前状态焦虑较高以及粗大运动功能分级系统(GMFCS)水平 III 和 IV 与较差的结局相关(p<0.05)。与接受分散注意力治疗前先接受 BART 治疗的参与者相比,在两次 BoNT-A 治疗中报告的疼痛和焦虑评分较低(p<0.05)。

结论

儿童在使用 BART 和分散注意力治疗时报告的疼痛相似。先接受 BART 治疗的儿童在两种治疗中均报告较低的疼痛和焦虑评分。

本文的意义

与分散注意力治疗相比,儿童在使用生物反馈放松训练(BART)时报告的疼痛相似。先接受 BART 治疗的儿童在两种 BoNT-A 治疗中均报告较低的疼痛和焦虑评分。年龄较小、术前状态焦虑和 GMFCS 水平 III 和 IV 预测疼痛体验更差。分散注意力治疗和 BART 是用于管理程序性疼痛的可接受的非药物干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验